Innovate to Eradicate

For 25 years, TB Alliance has led the global movement to discover, develop, and deliver new and improved TB treatments. After transforming drug-resistant TB therapy, we’re working on a next suite of innovations that could set the stage for ending TB. Our 25th Anniversary series shares perspectives from various thought leaders on the past, present, and future of TB drug development.

The Latest from TB Alliance

We cannot afford to stop until our treatments are available to everyone who needs them.

TB By The Numbers

Million
Tuberculosis (TB) is a global pandemic, killing someone approximately every 24 seconds — about 1.3 million people every year.
6-Months
Too many people with TB are still given older regimens that too too long to cure, are too complicated to administer, and can be toxic.
+ Projects
Promise in the pipeline means new hope in stopping TB.
TRANSFORMING TB TREATMENT

Charting the Course

We’ve all come to know the impact of infectious diseases, but we also know the power of science.

More News:

TB Alliance manages the largest pipeline of new TB drugs in history.

Latest News